Recognition of Abnormal Pediatric Blood Pressures in Primary Care
NCT ID: NCT00130663
Last Updated: 2007-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2006-01-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PDA blood pressure screening program and chart reminder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented measured blood pressure and height
* Between the ages of 3 years and 17 years
Exclusion Criteria
* Older than 17 years of age
* No documented blood pressure measurement
* Not a health supervision encounter
3 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nationwide Children's Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas J McLaughlin, MD
Role: PRINCIPAL_INVESTIGATOR
Pediatric Academic Association/Ohio State University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
219405
Identifier Type: -
Identifier Source: secondary_id
219405
Identifier Type: -
Identifier Source: org_study_id